Bioavailability Drug Delivery Systems Gene Therapy Genetics 
Roots Analysis
MAY 21, 2024
Over the last decade, one of the major challenges faced by pharmaceutical companies across the globe is low drug solubility. In fact, it has been observed that around 40% of the pharmaceutical drugs approved by regulatory organizations exhibit poor bioavailability / solubility.
XTalks
AUGUST 30, 2022
We know that a lot of different pathologies, especially as we’ve entered the era of molecular medicine and gene therapies, cause many of the same symptoms and work through final common pathways. Sometimes we can engage with the target that we’re interested in, but very often these drugs get through the entire brain.
Expert insights. Personalized for you.
40 
Let's personalize your content